This company listing is no longer active
4541 Stock Overview
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nichi-Iko Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥35.00 |
| 52 Week High | JP¥804.00 |
| 52 Week Low | JP¥35.00 |
| Beta | -0.66 |
| 1 Month Change | -20.45% |
| 3 Month Change | -57.83% |
| 1 Year Change | -95.49% |
| 3 Year Change | -97.27% |
| 5 Year Change | -97.95% |
| Change since IPO | -98.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4541 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -2.8% | -3.0% | -4.7% |
| 1Y | -95.5% | 2.7% | 26.3% |
Return vs Industry: 4541 underperformed the JP Pharmaceuticals industry which returned 9% over the past year.
Return vs Market: 4541 underperformed the JP Market which returned 1.6% over the past year.
Price Volatility
| 4541 volatility | |
|---|---|
| 4541 Average Weekly Movement | 17.0% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4541's share price has been volatile over the past 3 months.
Volatility Over Time: 4541's weekly volatility has decreased from 25% to 17% over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 2,656 | Shingo Iwamoto | www.nichiiko.co.jp |
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs.
Nichi-Iko Pharmaceutical Co., Ltd. Fundamentals Summary
| 4541 fundamental statistics | |
|---|---|
| Market cap | JP¥24.64b |
| Earnings (TTM) | -JP¥160.44b |
| Revenue (TTM) | JP¥182.88b |
0.1x
P/S Ratio-0.2x
P/E RatioIs 4541 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4541 income statement (TTM) | |
|---|---|
| Revenue | JP¥182.88b |
| Cost of Revenue | JP¥195.69b |
| Gross Profit | -JP¥12.81b |
| Other Expenses | JP¥147.63b |
| Earnings | -JP¥160.44b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -227.92 |
| Gross Margin | -7.01% |
| Net Profit Margin | -87.73% |
| Debt/Equity Ratio | -389.9% |
How did 4541 perform over the long term?
See historical performance and comparison